Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
RTO Stock Forecast 2026-2027
$34.06
Current Price
$17.52B
Market Cap
Buy 3
Hold 1
Sell 0
Wall St Analyst Ratings
Distance to RTO Price Targets
+12.7%
To High Target of $38.40
+5.7%
To Median Target of $36.00
-0.2%
To Low Target of $34.00
RTO Price Momentum
-0.8%
1 Week Change
+10.5%
1 Month Change
+49.4%
1 Year Change
+15.6%
Year-to-Date Change
-1.8%
From 52W High of $34.67
+53.2%
From 52W Low of $22.23
📊 TOP ANALYST CALLS
Did RTO Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Rentokil is one of their latest high-conviction picks.
Latest RTO Stock Price Targets & Analyst Predictions
Based on our analysis of 7 Wall Street analysts, RTO has a bullish consensus with a median price target of $36.00 (ranging from $34.00 to $38.40). The overall analyst rating is Strong Buy (8.5/10). Currently trading at $34.06, the median forecast implies a 5.7% upside. This outlook is supported by 3 Buy, 1 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
RTO Analyst Ratings
3
Buy
1
Hold
0
Sell
RTO Price Target Range
Low
$34.00
Average
$36.00
High
$38.40
Current: $34.06
Latest RTO Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for RTO.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Mar 12, 2026 | UBS | Nicole Manion | Buy | Upgrade | $N/A |
| Mar 10, 2026 | Oppenheimer | Ian Zaffino | Outperform | Maintains | $35.00 |
| Nov 21, 2025 | JP Morgan | Jane Sparrow | Overweight | Reinstates | $N/A |
| Oct 7, 2025 | Bernstein | Will Kirkness | Outperform | Upgrade | $N/A |
| Sep 19, 2024 | Redburn Atlantic | Oliver Davies | Neutral | Downgrade | $N/A |
| Jul 1, 2024 | UBS | Neutral | Upgrade | $N/A | |
| Mar 18, 2024 | Exane BNP Paribas | Outperform | Upgrade | $N/A | |
| Jan 24, 2024 | B of A Securities | Simona Sarli | Neutral | Downgrade | $29.00 |
| May 22, 2023 | Oppenheimer | Ian Zaffino | Outperform | Maintains | $47.00 |
Rentokil Initial plc Sponsored ADR (RTO) Competitors
The following stocks are similar to Rentokil based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Rentokil Initial plc Sponsored ADR (RTO) Financial Data
Rentokil Initial plc Sponsored ADR has a market capitalization of $17.52B with a P/E ratio of 59.8x. The company generates $6.91B in trailing twelve-month revenue with a 6.8% profit margin.
Revenue growth is +5.8% quarter-over-quarter, while maintaining an operating margin of +13.0% and return on equity of +5.4%.
Valuation Metrics
Market Cap
$17.52B
Enterprise Value
$89.47B
P/E Ratio
59.8x
PEG Ratio
20.3x
Price/Sales
2.5x
Growth & Margins
Revenue Growth (YoY)
+5.8%
Gross Margin
N/A
Operating Margin
+13.0%
Net Margin
+6.8%
EPS Growth
+95.8%
Financial Health
Cash/Price Ratio
+2.8%
Current Ratio
1.2x
Debt/Equity
112.0x
ROE
+5.4%
ROA
+4.0%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Rentokil Initial plc Sponsored ADR (RTO) Business Model
About Rentokil Initial plc Sponsored ADR
What They Do
Provides pest control and hygiene services globally.
Business Model
The company generates revenue by offering a wide range of pest control, hygiene, and plants services to various sectors, including food safety, hospitality, healthcare, and commercial offices. As a UK-based company, it allows U.S. investors to purchase shares through American Depositary Receipts (ADRs), facilitating international investment.
Additional Information
Rentokil Initial operates in over 80 countries and is recognized for its commitment to sustainability and innovation in the pest control and hygiene industry. The company's strategic focus on expanding its global presence provides investors with opportunities for growth and diversification.
Company Information
Sector
Industrials
Industry
Specialty Business Services
Employees
63,388
CEO
Mr. Michael A. Duffy Jr.
Country
United Kingdom
IPO Year
1996
Website
www.rentokil-initial.comRentokil Initial plc Sponsored ADR (RTO) Latest News & Analysis
Latest News
Quick Summary
Rentokil Initial PLC reported Q1 revenue of $1.68 billion, up 4.3% year-over-year, driven by pricing and demand growth in North America, with organic growth at 3.4%.
Why It Matters
Rentokil's steady growth and rising revenues indicate strong market demand, particularly in North America, suggesting potential for continued profitability and positive investor sentiment.
Source: Proactive Investors
Market Sentiment:
Positive
Quick Summary
Rentokil Initial plc (RTO) held a Q1 2026 sales and trading call, detailing financial performance and business updates. Further specifics on revenue and strategic initiatives were discussed.
Why It Matters
The Rentokil Initial plc Q1 2026 sales report provides insights into the company's financial performance and growth trends, influencing investor sentiment and stock valuation.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
UBS upgraded Rentokil Initial PLC to 'buy' with a 12-month price target of 540p, suggesting an 11% upside from the current 488p, citing a potential volume increase in North American pest control strategy.
Why It Matters
UBS's upgrade of Rentokil to 'buy' signals potential for an 11% price increase, driven by strategic changes in North America, indicating growth prospects and long-term value.
Source: Proactive Investors
Market Sentiment:
Positive
Quick Summary
Rentokil Initial has filed its Annual Report for 2025 and the notice for the 2026 AGM with the FCA, available for inspection. Documents are also published on their website.
Why It Matters
The filing of the Annual Report and AGM notice provides critical financial insights and governance details, influencing investor sentiment and decision-making regarding the company's performance and strategy.
Source: Accesswire
Market Sentiment:
Neutral
Quick Summary
UBS upgraded Rentokil Initial PLC (LSE:RTO) from neutral to buy, raising the price target from 430p to 540p, citing an end to market share losses in North America.
Why It Matters
UBS's upgrade of Rentokil to buy and increased price target signals improved growth prospects, potentially boosting investor confidence and driving stock demand.
Source: Proactive Investors
Market Sentiment:
Positive
Quick Summary
Rentokil Initial plc (RTO) shows stabilization in 2025 with improved North America growth. Elevated leverage at 7.5x free cash flow and complex reporting impact valuation.
Why It Matters
Rentokil's stabilization signals potential for recovery, but ongoing earnings adjustments and high leverage raise concerns. This may affect valuation and investor confidence in financial health.
Source: Seeking Alpha
Market Sentiment:
Positive
Frequently Asked Questions About RTO Stock
What is Rentokil Initial plc Sponsored ADR's (RTO) stock forecast for 2026?
Based on our analysis of 7 Wall Street analysts, Rentokil Initial plc Sponsored ADR (RTO) has a median price target of $36.00. The highest price target is $38.40 and the lowest is $34.00.
Is RTO stock a good investment in 2026?
According to current analyst ratings, RTO has 3 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $34.06. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for RTO stock?
Wall Street analysts predict RTO stock could reach $36.00 in the next 12 months. This represents a 5.7% increase from the current price of $34.06. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Rentokil Initial plc Sponsored ADR's business model?
The company generates revenue by offering a wide range of pest control, hygiene, and plants services to various sectors, including food safety, hospitality, healthcare, and commercial offices. As a UK-based company, it allows U.S. investors to purchase shares through American Depositary Receipts (ADRs), facilitating international investment.
What is the highest forecasted price for RTO Rentokil Initial plc Sponsored ADR?
The highest price target for RTO is $38.40 from at , which represents a 12.7% increase from the current price of $34.06.
What is the lowest forecasted price for RTO Rentokil Initial plc Sponsored ADR?
The lowest price target for RTO is $34.00 from at , which represents a -0.2% decrease from the current price of $34.06.
What is the overall RTO consensus from analysts for Rentokil Initial plc Sponsored ADR?
The overall analyst consensus for RTO is bullish. Out of 7 Wall Street analysts, 3 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $36.00.
How accurate are RTO stock price projections?
Stock price projections, including those for Rentokil Initial plc Sponsored ADR, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: April 21, 2026 10:20 AM UTC